MedPath

Effect of Anthum graveolen on vulvovaginal Candidiasis

Phase 2
Conditions
vulvovaginal Candidiasis.
Candidiasis of vulva and vagina
Registration Number
IRCT2016101828789N4
Lead Sponsor
Mashhad University of Medical Sciences, Vice chancellor for research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Inclusion criteria consisted of married women aged 15- 49 years; have received a clinical diagnosis of vaginal candidiasis; have had a positive culture for vaginal candidiasis. Exclusion criteria: were pregnancy or breast-feeding; received antibiotic drugs and topical and systemic anti-fungal drugs within one month before; had three or more episode of VVC per year; missed more than one suppositories or vaginal tablet uses within seven consecutive days; had hypersensitivity to clotrimazole or Anthum graveolen.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Itching. Timepoint: before intervention and 7 days after intervention. Method of measurement: 4-point likert-type scale.;Burning. Timepoint: before intervention and 7 days after intervention. Method of measurement: 4-point likert-type scale.;Vaginal discharge. Timepoint: before intervention and 7 days after intervention. Method of measurement: 4-point likert-type scale.
Secondary Outcome Measures
NameTimeMethod
Improve Of Vulvovaginal Candidiasis. Timepoint: before intervention and7 days after intervention. Method of measurement: Microscopic evaluation.
© Copyright 2025. All Rights Reserved by MedPath